Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
Completed
IQVIA
Phase 2
The purpose of this study is to investigate the dose response of RPL554 in patients with
moderate to severe CHRONIC OBSTRUCTIVE PULMONARY DISEASE that are still symptomatic despite
treatment with a stable background of tiotropium over 4 weeks of treatment. This study is
intended to support optimal dose selection for a Phase III program evaluating RPL554 as an
add-on treatment to standard of care therapy.
Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
Completed
Iqvia Pty Ltd
Phase 2
The purpose of this study is to investigate the dose response of RPL554 in patients with
moderate to severe CHRONIC OBSTRUCTIVE PULMONARY DISEASE that are still symptomatic despite
treatment with a stable background of tiotropium over 4 weeks of treatment. This study is
intended to support optimal dose selection for a Phase III program evaluating RPL554 as an
add-on treatment to standard of care therapy.
Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
Completed
LGC Limited
Phase 2
The purpose of this study is to investigate the dose response of RPL554 in patients with
moderate to severe CHRONIC OBSTRUCTIVE PULMONARY DISEASE that are still symptomatic despite
treatment with a stable background of tiotropium over 4 weeks of treatment. This study is
intended to support optimal dose selection for a Phase III program evaluating RPL554 as an
add-on treatment to standard of care therapy.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
